Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Industry's Generic Labeling Rule Approach Finds Support With House Appropriators

This article was originally published in The Pink Sheet Daily

Executive Summary

Congressional recommendation largely mirrors industry's 'Expedited Agency Review' proposal for making safety updates.


Related Content

FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield